| Pharmaceutical Information |
| Drug Name |
Technetium tc-99m pyrophosphate |
| Drug ID |
BADD_D02131 |
| Description |
A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities. |
| Indications and Usage |
For use as a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction [FDA Label]. May also be used to image gated blood pools and detect gastrointetinal bleeding. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB09165
|
| KEGG ID |
Not Available
|
| MeSH ID |
D016698
|
| PubChem ID |
6452753
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
5L76I61H2B
|
| Synonyms |
Technetium Tc 99m Pyrophosphate | Tc-PYP | Tc PYP | Tc 99m-Pyrophosphate | Tc 99m Pyrophosphate | 99mTc-Pyrophosphate | 99mTc Pyrophosphate | Diphosphoric Acid, Technetium Salt | Technetium Tc 99m Pyrophosphate, Tc(3+) Salt (3:4) | Technetium Tc 99m Pyrophosphate, Tc(4+) Salt (1:1) |
|
| Chemical Information |
| Molecular Formula |
O7P2Tc |
| CAS Registry Number |
52997-54-3 |
| SMILES |
[O-]P(=O)([O-])OP(=O)([O-])[O-].[Tc+4] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
